Bruno JJ Ellis JJ Herbal use among US elderly: 2002 National Health Interview Survey Ann Pharmacother 2005 39 643-648 
Slone Epidemiology Center Patterns of Medication Use in the United States 2006. A Report from the Slone Survey 2006 Boston, Mass. Slone Epidemiology Center at Boston University 
CDC Incidence of Diagnosed Diabetes Per 1000 Population Aged 18&#8211;79 Years, by Sex and Age, United States, 1997&#8211;2005 2007 Atlanta, Georgia Centers for Disease Control and Prevention (CDC) Available at:
Marshall S Bacote V Traxinger R Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance J Biol Chem 1991 266 4706-4712 
Copeland RJ Bullen JW Hart GW Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab 2008 295 E17-E28 
Pham T Cornea A Blick KE Jenkins A Scofield RH Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance Am J Med Sci 2007 333 333-339 
Biggee BA Blinn CM Nuite M Silbert JE McAlindon TE Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis Ann Rheum Dis 2007 66 260-262 
Dahmer S Schiller RM Glucosamine Am Fam Physician 2008 78 471-476 
Shankar RR Zhu J-S Baron AD Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus Metabolism 1998 47 573-577 
Muniyappa R Karne RJ Hall G Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects Diabetes 2006 55 3142-3150 
Quastel JH Intestinal absorption of sugars and amino acids Am J Clin Nutr 1960 8 137-146 
Hastings TH Landau BR Specificity of sugar transport by the intestine of the hamster Am J Physiol 1960 198 99-102 
Neale RJ Wiseman G The use of dietary-restricted rat intestine for active transport studies J Physiol 1969 205 159-178 
Faust RG Leadbetter MG Plenge RK McCaslin AJ Active sugar transport by the small intestine. The effects of sugars, amino acids, hexosamines, sulfhydryl-reacting compounds, and cations on the preferential binding of D-glucose to tris-disrupted brush borders J Gen Physiol 1968 52 482-494 
Hirayama BA Loo DD D&#237;ez-Sampedro A Sodium-dependent reorganization of the sugar-binding site of SGLT1 Biochemistry 2007 46 13391-1406 
Roda A Sabatini L Barbieri A Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma J Chromatogr B 2006 844 119-126 
Biggee BA Blinn CM McAlindon TE Nuite M Silbert JE Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness Ann Rheum Dis 2006 65 222-226 
Persiani S Rotini R Trisolino G Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose Osteoarthritis Cartilage 2007 15 764-772 
Persiani S Roda E Rovati LC Locatelli M Giacovelli G Roda A Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man Osteoarthritis Cartilage 2005 13 1041-1049 
Setnikar I Rovati LC Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review Arzneimittelforschung 2001 51 699-725 
Adebowale A Du J Liang Z Leslie JL Eddington ND The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs Biopharm Drug Dispos 2002 23 217-225 
Du J White N Eddington ND The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse Biopharm Drug Dispos 2004 25 109-116 
Laverty S Sandy JD Celeste C Vachon P Marier J-F Plaas AH Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses Arthritis Rheum 2005 52 181-191 
Aghazadeh-Habashi A Sattari S Pasutto F Jamali F Single dose pharmacokinetics and bioavailability of glucosamine in the rat J Pharm Pharm Sci 2002 5 181-184 
Setnikar I Palumbo R Canali S Zanolo G Pharmacokinetics of glucosamine in man Arzneimittelforschung 1993 43 1109-1113 
Aghazadeh-Habashi A Ibrahim A Carran J Anastassiades T Jamali F Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat J Pharm Pharm Sci 2006 9 359-364 
Crociani F Alessandrini A Mucci MM Biavati B Degradation of complex carbohydrates by Bifidobacterium spp Int J Food Microbiol 1994 24 199-210 
Salyers AA Vercellotti JR West SEH Wilkins TD Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon Appl Environ Microbiol 1977 33 319-322 
Kajinuma H Kuzuya T Ide T Tyler JM Effects of glucosamine on insulin and glucagon secretion in dogs and ducks Endocrinol Jpn 1975 22 517-523 
Giaccari A Morviducci L Zorretta D In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia Diabetologia 1995 38 518-524 
Baron AD Zhu J-S Zhu J-H Weldon H Maianu L Garvey WT Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity J Clin Invest 1995 96 2792-2801 
Rossetti L Hawkins M Chen W Gindi J Barzilai N In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats J Clin Invest 1995 96 132-140 
Hawkins M Angelov I Liu R Barzilai N Rossetti L The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake J Biol Chem 1997 272 4889-4895 
Virkam&#228;ki A Daniels MC H&#228;mal&#228;inen S Utriainen T McClain D Yki-J&#228;rvinen H Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues Endocrinology 1997 138 2501-2507 
Holm&#228;ng A Nilsson C Niklasson M Larsson BM Lonroth P Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin Diabetes 1999 48 106-111 
Kim YB Zhu JS Zierath JR Shen HQ Baron AD Kahn BB Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle Diabetes 1999 48 310-320 
Patti ME Virkamaki A Landaker EJ Kahn CR Yki-Jarvinen H Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle Diabetes 1999 48 1562-1571 
Spampinato D Giaccari A Trischitta V Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation Metabolism 2003 52 1092-1095 
Robertson MW Dunshea FR Goddard ME Leury BJ Stimulation of the hexosamine biosynthetic pathway by glucosamine in sheep Asia Pac J Clin Nutr 2005 14 suppl S79 
Monauni T Zenti MG Cretti A Effects of glucosamine infusion on insulin secretion and insulin action in humans Diabetes 2000 49 926-935 
Pouwels M-J Jacobs JR Span PN Lutterman JA Smits P Tack CJ Short-term glucosamine infusion does not affect insulin sensitivity in humans J Clin Endocrinol Metab 2001 86 2099-2103 
Oguchi M Miyatake Y Ayabe J Akamatsu N Phosphorylation of D-glucosamine by rat liver glucokinase J Biochem 1975 77 1117-1121 
Agius L Stubbs M Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites Biochem J 2000 346 413-421 
Albert SG Oiknine RF Parseghian S Mooradian AD Haas MJ McPherson T The effect of glucosamine on serum HDL cholesterol and apolipoprotein AI levels in people with diabetes Diabetes Care 2007 30 2800-2803 
Yu JG Boies SM Olefsky JM The effect of oral glucosamine sulfate on insulin sensitivity in human subjects Diabetes Care 2003 26 1941-1942 
Scroggie DA Albright A Harris MD The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial Arch Intern Med 2003 163 1587-1590 
Tapadinhas MJ Rivera IC Bignamini AA Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal Pharmatherapeutica 1982 3 157-168 
Clegg DO Reda DJ Harris CL Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med 2006 354 795-808 
Tannis AJ Barban J Conquer JA Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals Osteoarthritis Cartilage 2004 12 506-511 
Hughes R Carr A A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee Rheumatology 2002 41 279-284 
Pavelk&#225; K Gatterova J Olejarova M Machacek S Giacovelli G Rovati LC Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 2002 162 2113-2123 
Reginster JY Deroisy R Rovati LC Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 2001 357 251-256 
Almada AL Harvey P Platt K Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in non-diabetic individuals FASEB J 2000 14 A750 [Abstract 521.15]
Giordano N Nardi P Senesi M Efficacia e tollerabilit&#224; della glucosamina solfato nel trattamento della gonartrosi. [The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis] Clin Ter 1996 147 99-105 
Noack W Fischer M Forster KK Rovati LC Setnikar I Glucosamine sulfate in osteoarthritis of the knee Osteoarthritis Cartilage 1994 2 51-59 
D'Ambrosio E Casa B Bompani R Scali G Scali M Glucosamine sulphate: a controlled clinical investigation in arthrosis Pharmatherapeutica 1981 2 504-508 
Drovanti A Bignamini AA Rovati AL Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation Clin Ther 1980 3 260-272 
Crolle G D'Este E Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation Curr Med Res Opin 1980 7 104-109 
Laferr&#232;re B Garcia-Lorda P Russell CD Pi-Sunyer FX Effect of oral glucosamine sulfate on serum leptin levels in human subjects Nutrition 2004 20 321-322 
Pujalte JM Llavore EP Ylescupidez FR Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis Curr Med Res Opin 1980 7 110-114 
Rovati LC Clinical research in osteoarthritis: design and results of short-term and long-term with disease-modifying drugs Int J Tissue React 1992 14 243-251 
Qiu GX Gao SN Giacovelli G Rovati L Setnikar I Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis Arzneimittelforschung 1998 48 469-474 
Valensi P Schwarz EH Hall M Felton AM Maldonato A Mathieu C Pre-diabetes essential action: a European perspective Diabetes Metab 2005 31 606-620 
IDF Prevalence estimates of diabetes mellitus (DM), 2010 Diabetes Atlas: The e-Atlas 2010 4th edn Brussels, Belgium The International Diabetes Federation (IDF) Available at:
EC Population Statistics: Detailed Tables 2004 Luxembourg Office for Official Publications of the European Communities Available at:
Lee YH Woo JH Choi SJ Ji JD Song GG Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis Rheumatol Int 2010 30 357-363 
Marshall S Nadeau O Yamasaki K Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels J Biol Chem 2004 279 35313-35319 
Heart E Choi WS Sung CK Glucosamine-induced insulin resistance in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 2000 278 E103-E112 
Echard BW Talpur NA Funk KA Bagchi D Preuss HG Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats Mol Cell Biochem 2001 225 85-91 
McNamara PS Barr SC Erb HN Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days Am J Vet Res 1996 57 1390-1394 
Stender S Astrup P Glucosamine and experimental atherosclerosis. Increased wet weight and charged composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine Atherosclerosis 1977 26 205-213 
